Former employees of an eye bank allege that intense pressure and insufficient oversight contributed to critical errors in handling and processing donor tissue. They claim that demanding quotas and inadequate quality controls compromised the integrity of procedures, potentially affecting transplant outcomes. The accusations highlight the need for more stringent regulations and transparent practices in the tissue banking industry to ensure patient safety and uphold donor trust.